Schizophrenia and Related Disorders Clinical Trial
— TSWOfficial title:
Cognitive Remediation Therapy for Patients With Serious Mental Illness Who Failed to Benefit From Supported Employment
Verified date | July 2020 |
Source | Fraser Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to help people with serious mental illness get and keep the job
they want by improving their thinking skills, using cognitive remediation therapy. For people
with serious mental illness, the Individual Placement and Support (IPS) Program is an
effective approach to help people become employed. Despite its general success, still only
55% of clients find employment. Most of that success occurs in the first three months; after
six months, the chances of finding competitive work are quite low. Among those who fail to
find employment with IPS, cognitive dysfunction is often a significant problem. The proposed
study will target IPS clients who have not found work after 3 months of employment-support
services: our hypothesis is that, after three months with no success, the addition of
cognitive remediation to IPS will improve employment rates (compared to those who continue to
receive IPS alone).
The proposed randomized controlled trial will use a single-blind study design, focused on IPS
clients who are slow to (or may never) find employment success. Specifically, the proposed
study will have two treatment arms: a) cognitive remediation added to continued IPS services,
and b) continued IPS services alone. The study will collaborate with IPS workers at 11 Mental
Health and Substance Use (MHSU) clinics to identify clients who are non-responders in the
first 3 months, and seek their consent to participate in the study. They will be randomized
to either TAU (continuation with IPS and other standard treatments), or TAU plus cognitive
remediation. The CRT will consist of computerized cognitive exercise practice, strategy
coaching, and teaching coping/compensatory strategies for 12 weeks. Clients will be assessed
at 3-time points: prior to the start of cognitive remediation ("baseline"), end-point
(3-month), and 6 months after the endpoint evaluation. Primary outcome measures will include
success at gaining a competitive job, total hours of competitive employment, and
neuropsychological measures of cognition.
Status | Completed |
Enrollment | 105 |
Est. completion date | May 25, 2020 |
Est. primary completion date | March 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Participants aged 19-60 years old - Enrolled in the IPS program for at least 3 months - Clinically stable (no changes to psychiatric medication and psychiatric hospitalization in the 30 days prior to intake) Exclusion Criteria: - History of traumatic brain injury - Neurological disorder - Developmental disability - Difficulty understanding written and spoken English |
Country | Name | City | State |
---|---|---|---|
Canada | Fraser Health: Royal Columbian Hospital | New Westminster | British Columbia |
Lead Sponsor | Collaborator |
---|---|
Fraser Health | Ministry of Social Development and Poverty Reduction, British Columbia |
Canada,
Bell MD, Zito W, Greig T, Wexler BE. Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up. Schizophr Res. 2008 Oct;105(1-3):18-29. doi: 10.1016/j.schres.2008.06.026. Epub 2008 Aug 19. — View Citation
Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004 Dec 15;72(1):41-51. Review. — View Citation
Kurtz MM, Wexler BE, Fujimoto M, Shagan DS, Seltzer JC. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophr Res. 2008 Jul;102(1-3):303-11. doi: 10.1016/j.schres.2008.03.023. Epub 2008 May 20. — View Citation
Marshall T, Goldberg RW, Braude L, Dougherty RH, Daniels AS, Ghose SS, George P, Delphin-Rittmon ME. Supported employment: assessing the evidence. Psychiatr Serv. 2014 Jan 1;65(1):16-23. doi: 10.1176/appi.ps.201300262. Review. — View Citation
McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial. Am J Psychiatry. 2007 Mar;164(3):437-41. — View Citation
McGurk SR, Mueser KT, Xie H, Welsh J, Kaiser S, Drake RE, Becker DR, Bailey E, Fraser G, Wolfe R, McHugo GJ. Cognitive Enhancement Treatment for People With Mental Illness Who Do Not Respond to Supported Employment: A Randomized Controlled Trial. Am J Psychiatry. 2015 Sep 1;172(9):852-61. doi: 10.1176/appi.ajp.2015.14030374. Epub 2015 May 22. — View Citation
McGurk SR, Mueser KT. Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophr Res. 2004 Oct 1;70(2-3):147-73. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Employment Outcomes | The number of hours client worked in the past 90 days. | 90 days | |
Secondary | Cognitive Functioning | Cognitive functioning will be measured using the Matrics Consensus Cognitive Battery. The MCCB has 10 tests that measures 7 cognitive domains: speed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning and problem solving, and social cognition. Raw scores will be converted to T-score for each domain. T-score has a mean of 50 and a standard deviation of 10. | 90 minutes | |
Secondary | Psychiatric Symptoms | Brief Psychiatric Rating Scale. The BPRS is a semi-structured interview of psychiatric symptoms over the past 2 weeks. There are 24 items rated from 1 to 7 with higher scores indicating more severe symptoms. | 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05083377 -
Clozapine Use Pattern in the Province of Seville
|
||
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Recruiting |
NCT06134661 -
Accelerated rTMS for Psychomotor Slowing
|
N/A | |
Completed |
NCT01433094 -
Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia
|
N/A | |
Terminated |
NCT05526833 -
An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study
|
N/A | |
Recruiting |
NCT05982158 -
Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices
|
N/A | |
Active, not recruiting |
NCT06175559 -
Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia
|
N/A | |
Active, not recruiting |
NCT05673941 -
"InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia
|
N/A | |
Recruiting |
NCT02916810 -
TMS for Symptom Reduction in Schizophrenia
|
N/A | |
Recruiting |
NCT05958875 -
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
|
Phase 4 | |
Recruiting |
NCT03525054 -
Semantic and Syntactic Computerized Analysis of Free Speech
|
||
Recruiting |
NCT05389345 -
tDCS and Executive Function Training for Schizophrenia
|
N/A | |
Completed |
NCT05601050 -
Linguistic Predictors of Outcomes in Psychosis
|
||
Completed |
NCT03075202 -
Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
|
||
Completed |
NCT03921450 -
Overcoming Psychomotor Slowing in Psychosis (OCoPS-P)
|
N/A | |
Completed |
NCT06231407 -
Increasing Medication Check Participation Through Applying CT-r
|
N/A | |
Recruiting |
NCT04478838 -
"Extended" (Alternate Day) Antipsychotic Dosing
|
Phase 4 | |
Completed |
NCT04366401 -
Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders
|
N/A | |
Completed |
NCT04612777 -
A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses
|
N/A | |
Not yet recruiting |
NCT06191965 -
MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
|
Phase 2/Phase 3 |